tirzepatide cvot Diabetes Distilled: SURPASS-CVOT – demonstrates cardiovascular benefit in secondary prevention Post hoc analysis of SURPASS-CVOT

Monthly Medication Cost from $169/mo Compounded tirzepatide (injection) $299/mo (single) or $399/3mo bundle at low dose INCLUDES Initial Lab Test Recent labs accepted Monthly Membership Fee None Coaching & Lifestyle Support Basic Basic Nutritional Support Not included Doctor Consultations Async clinician review Shipping Cold-chain included Cancellation & Billing Excellent No retention pressure

The key takeaway is that MEDVi itself does not prescribe medications

Dosing is individualized based on clinical findings there is no standard package

"The availability of Zepbound in US pharmacies is the first step, but we have to work hand-in-hand with employers, government and healthcare industry partners to remove barriers and make Zepbound available to those who need it

Most providers prescribing higher doses will switch patients to the 20mg/mL concentration to avoid this issue